BioSpace News Archive

Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), today announced that its wholly-owned subsidiary, Dialco Medical Inc. (“Dialco”) has received approval of a protocol amendment to its DIMI usability trial from the United States Federal Food and Drug Agency (“FDA”).

Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty products and solutions, will report its fourth quarter and full year 2021 financial performance in a press release before the market opens on Monday, February 28, 2022.

IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) (“IceCure” or the “Company”), developer of minimally-invasive cryoablation technology, the ProSense® System, that destroys tumors by freezing as an alternative to surgical tumor removal, today announced preliminary unaudited year-end financial results for the twelve months ended December 31, 2021.

NTT Research, Inc., a subsidiary of NTT (TYO:9432), and Cornell University today announced that scientists representing their organizations have introduced an algorithm that applies deep neural network training to controllable physical systems and have demonstrated its implementation on three types of unconventional hardware.

BIONIK Laboratories Corp. (OTCQB: BNKL) (“BIONIK” or the “Company”), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced its participation in the American Physical Therapy Association (APTA) Conference in San Antonio, Texas from February 2–5, 2022.

Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced that the first patient has been dosed in the multinational Phase 1b/2 trial of its all-oral combination product, Nana-val.

SYNAPS Dx (SDx), is pleased to announce the release of its white paper, “Supporting Payer Treatment Reimbursement Decisions for Alzheimer’s Disease: DISCERN™ Test Provides Definitive Diagnosis of Alzheimer’s Disease and Degenerative Pathologies Vs. Other Forms of Dementia.

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it achieved accreditation through the Accreditation Commission for Health Care (ACHC) as a specialty pharmacy with distinction in rare disease and orphan drugs.

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the U.S. Food & Drug Administration (FDA) approved VONVENDI® [von Willebrand factor (Recombinant)] for routine prophylaxis to reduce the frequency of bleeding episodes in patients with severe Type 3 von Willebrand disease (VWD) receiving on-demand therapy.

Helix BioPharma Corp. today announced the voting results of the Company’s annual and special meeting of shareholders held on January 28, 2022.